Live feed
Filing
SC 13D
SC 13D0001193125-23-243053·AMGEN INC
Schedule 13D ownership disclosure
Neumora Therapeutics Inc
Security class unavailable · CUSIP: 640979100
Event date: 2023-09-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 23.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-243053
- Form type
- SC 13D
- Filer
- AMGEN INC
- CIK
- CIK 318154
- Filed
- Sep 27, 2023
- Reporting period
- Sep 19, 2023
- Description
- Schedule 13D beneficial ownership